VISION Data Report 2022

VII. Metastasis

Biopsy At the time of diagnosis of metastasis was a biopsy taken?

Treatment At the time of diagnosis with metastasis being reported what treatment did the patient have? Check all that apply.

67%

10%

Focal Ablation

16%

Immunotherapy

33%

24%

Liver Directed Therapy*

6%

9%

Observation

16%

Surgical resection

6%

Tebentafusp

Yes

No

Unknown

13%

Other

Of the 67% of patients who reported “Yes,” the following gene mutations were found in the biopsy tissue:

The 13% of patients who responded “Other” reported:

25% LEAP trial

25% Autologous Vaccine

Unknown 60%

GNAQ 7%

BAP1 7%

Not applicable

7%

GNA11 12%

25% Cyberknife

25% C-met trial

* Patients reported immunoembolization, chemoembolization and radioembolization.

2022 VISION Registry Data Report

44

Made with FlippingBook Ebook Creator